Accession Number: | 0001179110-20-009968 |
Date: | 2020-09-24 |
Issuer: | STRONGBRIDGE BIOPHARMA PLC (SBBP) |
Original Submission Date: |
GILL DAVID N
900 NORTHBROOK DRIVE
SUITE 200
TREVOSE, PA 19053
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
ORDINARY SHARES | 2020-09-24 | P | 8,000 | a | $2.13 | 74,896 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the price reported in column 4 is a weighted average price. these shares were purchased on the open market in multiple transactions at prices ranging from $2.13 to $2.14, inclusive. the reporting person undertakes to provide to the issuer, to any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares purchased at each separate price. |